aluates Reports

$ 0.0

Automative

Global Iptacopan Hydrochloride Capsules Market Research Report 2026

Published Date: 2026-05-15

Report Code: QYRE-Auto-33M20269

BUY CHAPTERS

Global Iptacopan Hydrochloride Capsules Market Research Report 2026

Code: QYRE-Auto-33M20269

Report

2026-05-15

Pages:102

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis Pharma

Iptacopan Hydrochloride Capsules Market Size

The global Iptacopan Hydrochloride Capsules market was valued at US$ 188 million in 2025 and is anticipated to reach US$ 950 million by 2032, at a CAGR of 11.3% from 2026 to 2032.

Iptacopan Hydrochloride Capsules Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Iptacopan Hydrochloride Capsules competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Iptacopan Hydrochloride Capsules are an oral, highly selective factor B inhibitor that reduces immune damage to the kidneys and related tissues by selectively inhibiting the overactivation of the complement alternative pathway. They are mainly used for the treatment of complement-mediated renal diseases such as IgA nephropathy and C3 glomerulopathy. As the world’s first oral targeted complement inhibitor approved for IgA nephropathy, it features convenient administration, a clear mechanism of action, and high patient compliance. It can significantly reduce proteinuria, delay renal function decline, and provide a novel non-immunosuppressive therapeutic option for patients with complement-related kidney diseases.In 2025, global Iptacopan Hydrochloride Capsules production reached approximately 1.2 million bottles.

As the world’s first oral highly selective factor B inhibitor, Iptacopan Hydrochloride Capsules have established an important clinical position in the field of complement-mediated renal diseases by virtue of their unique mechanism of targeted inhibition of the complement alternative pathway. Its core advantages lie in convenient administration and high compliance, which can effectively reduce proteinuria and delay renal function decline, providing a novel non-immunosuppressive treatment option for patients with limited previous therapeutic choices, such as those with IgA nephropathy and C3 glomerulopathy.

In terms of market layout, the drug is originally researched and exclusively manufactured by Novartis, and has been approved for marketing in many major global markets. Meanwhile, it is simultaneously promoting indication expansion and medical insurance coverage in China, which has significantly improved its accessibility. In the competitive landscape, its oral dosage form differentiates it from traditional injectable complement inhibitors, giving it a first-mover advantage in the complement drug sector. Furthermore, ongoing clinical studies on a variety of complement-related diseases are continuously expanding its market potential and application scenarios. Overall, the drug is at a critical stage of penetration from core indications to multiple disease areas, with sufficient market growth momentum and broad prospects for future development.

This report delivers a comprehensive overview of the global Iptacopan Hydrochloride Capsules market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Iptacopan Hydrochloride Capsules. The Iptacopan Hydrochloride Capsules market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Iptacopan Hydrochloride Capsules market comprehensively. Regional market sizes by Type, by Application, by Combination Therapy, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Iptacopan Hydrochloride Capsules manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Iptacopan Hydrochloride Capsules Market Report

Report Metric	Details
Report Name	Iptacopan Hydrochloride Capsules Market
Accounted market size in 2025	US$ 188 million
Forecasted market size in 2032	US$ 950 million
CAGR	11.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	14 capsules/box 56 capsules/box
Segment by Combination Therapy	Combined With Renin-Angiotensin-Aldosterone System Inhibitors Combined With Corticosteroids
Segment by Sales Channels	Hospital Retail Online
by Application	Treatment Of IgA Nephropathy Treatment Of C3 Glomerulopathy Treatment Of Complement-Mediated Renal Diseases Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Combination Therapy, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Iptacopan Hydrochloride Capsules manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Iptacopan Hydrochloride Capsules sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Iptacopan Hydrochloride Capsules Market growing?

Ans: The Iptacopan Hydrochloride Capsules Market witnessing a CAGR of 11.3% during the forecast period 2026-2032.

What is the Iptacopan Hydrochloride Capsules Market size in 2032?

Ans: The Iptacopan Hydrochloride Capsules Market size in 2032 will be US$ 950 million.

Who are the main players in the Iptacopan Hydrochloride Capsules Market report?

Ans: The main players in the Iptacopan Hydrochloride Capsules Market are Novartis Pharma

What are the Application segmentation covered in the Iptacopan Hydrochloride Capsules Market report?

Ans: The Applications covered in the Iptacopan Hydrochloride Capsules Market report are Treatment Of IgA Nephropathy, Treatment Of C3 Glomerulopathy, Treatment Of Complement-Mediated Renal Diseases, Others

What are the Type segmentation covered in the Iptacopan Hydrochloride Capsules Market report?

Ans: The Types covered in the Iptacopan Hydrochloride Capsules Market report are 14 capsules/box, 56 capsules/box

1 Iptacopan Hydrochloride Capsules Market Overview

1.1 Product Definition

1.2 Iptacopan Hydrochloride Capsules by Type

1.2.1 Global Iptacopan Hydrochloride Capsules Market Value by Type: 2025 vs 2032

1.2.2 14 capsules/box

1.2.3 56 capsules/box

1.3 Iptacopan Hydrochloride Capsules by Combination Therapy

1.3.1 Global Iptacopan Hydrochloride Capsules Market Value by Combination Therapy: 2025 vs 2032

1.3.2 Combined With Renin-Angiotensin-Aldosterone System Inhibitors

1.3.3 Combined With Corticosteroids

1.4 Iptacopan Hydrochloride Capsules by Sales Channels

1.4.1 Global Iptacopan Hydrochloride Capsules Market Value by Sales Channels: 2025 vs 2032

1.4.2 Hospital

1.4.3 Retail

1.4.4 Online

1.5 Iptacopan Hydrochloride Capsules by Application

1.5.1 Global Iptacopan Hydrochloride Capsules Market Value by Application: 2025 vs 2032

1.5.2 Treatment Of IgA Nephropathy

1.5.3 Treatment Of C3 Glomerulopathy

1.5.4 Treatment Of Complement-Mediated Renal Diseases

1.5.5 Others

1.6 Global Iptacopan Hydrochloride Capsules Market Size Estimates and Forecasts

1.6.1 Global Iptacopan Hydrochloride Capsules Revenue 2021–2032

1.6.2 Global Iptacopan Hydrochloride Capsules Sales 2021–2032

1.6.3 Global Iptacopan Hydrochloride Capsules Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Iptacopan Hydrochloride Capsules Market Competition by Manufacturers

2.1 Global Iptacopan Hydrochloride Capsules Sales Market Share by Manufacturers (2021–2026)

2.2 Global Iptacopan Hydrochloride Capsules Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Iptacopan Hydrochloride Capsules Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Iptacopan Hydrochloride Capsules, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Iptacopan Hydrochloride Capsules, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Iptacopan Hydrochloride Capsules, Product Types and Applications

2.7 Global Key Manufacturers of Iptacopan Hydrochloride Capsules, Date of Entry into the Industry

2.8 Global Iptacopan Hydrochloride Capsules Market Competitive Situation and Trends

2.8.1 Global Iptacopan Hydrochloride Capsules Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Iptacopan Hydrochloride Capsules Players Market Share by Revenue

2.8.3 Global Iptacopan Hydrochloride Capsules Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Iptacopan Hydrochloride Capsules Market Scenario by Region

3.1 Global Iptacopan Hydrochloride Capsules Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Iptacopan Hydrochloride Capsules Sales by Region: 2021–2032

3.2.1 Global Iptacopan Hydrochloride Capsules Sales by Region: 2021–2026

3.2.2 Global Iptacopan Hydrochloride Capsules Sales by Region: 2027–2032

3.3 Global Iptacopan Hydrochloride Capsules Revenue by Region: 2021–2032

3.3.1 Global Iptacopan Hydrochloride Capsules Revenue by Region: 2021–2026

3.3.2 Global Iptacopan Hydrochloride Capsules Revenue by Region: 2027–2032

3.4 North America Iptacopan Hydrochloride Capsules Market Facts & Figures by Country

3.4.1 North America Iptacopan Hydrochloride Capsules Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Iptacopan Hydrochloride Capsules Sales by Country (2021–2032)

3.4.3 North America Iptacopan Hydrochloride Capsules Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Iptacopan Hydrochloride Capsules Market Facts & Figures by Country

3.5.1 Europe Iptacopan Hydrochloride Capsules Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Iptacopan Hydrochloride Capsules Sales by Country (2021–2032)

3.5.3 Europe Iptacopan Hydrochloride Capsules Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Iptacopan Hydrochloride Capsules Market Facts & Figures by Region

3.6.1 Asia Pacific Iptacopan Hydrochloride Capsules Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Iptacopan Hydrochloride Capsules Sales by Region (2021–2032)

3.6.3 Asia Pacific Iptacopan Hydrochloride Capsules Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Iptacopan Hydrochloride Capsules Market Facts & Figures by Country

3.7.1 Latin America Iptacopan Hydrochloride Capsules Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Iptacopan Hydrochloride Capsules Sales by Country (2021–2032)

3.7.3 Latin America Iptacopan Hydrochloride Capsules Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Iptacopan Hydrochloride Capsules Market Facts & Figures by Country

3.8.1 Middle East and Africa Iptacopan Hydrochloride Capsules Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Iptacopan Hydrochloride Capsules Sales by Country (2021–2032)

3.8.3 Middle East and Africa Iptacopan Hydrochloride Capsules Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Iptacopan Hydrochloride Capsules Sales by Type (2021–2032)

4.1.1 Global Iptacopan Hydrochloride Capsules Sales by Type (2021–2026)

4.1.2 Global Iptacopan Hydrochloride Capsules Sales by Type (2027–2032)

4.1.3 Global Iptacopan Hydrochloride Capsules Sales Market Share by Type (2021–2032)

4.2 Global Iptacopan Hydrochloride Capsules Revenue by Type (2021–2032)

4.2.1 Global Iptacopan Hydrochloride Capsules Revenue by Type (2021–2026)

4.2.2 Global Iptacopan Hydrochloride Capsules Revenue by Type (2027–2032)

4.2.3 Global Iptacopan Hydrochloride Capsules Revenue Market Share by Type (2021–2032)

4.3 Global Iptacopan Hydrochloride Capsules Price by Type (2021–2032)

5 Segment by Application

5.1 Global Iptacopan Hydrochloride Capsules Sales by Application (2021–2032)

5.1.1 Global Iptacopan Hydrochloride Capsules Sales by Application (2021–2026)

5.1.2 Global Iptacopan Hydrochloride Capsules Sales by Application (2027–2032)

5.1.3 Global Iptacopan Hydrochloride Capsules Sales Market Share by Application (2021–2032)

5.2 Global Iptacopan Hydrochloride Capsules Revenue by Application (2021–2032)

5.2.1 Global Iptacopan Hydrochloride Capsules Revenue by Application (2021–2026)

5.2.2 Global Iptacopan Hydrochloride Capsules Revenue by Application (2027–2032)

5.2.3 Global Iptacopan Hydrochloride Capsules Revenue Market Share by Application (2021–2032)

5.3 Global Iptacopan Hydrochloride Capsules Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Novartis Pharma

6.1.1 Novartis Pharma Company Information

6.1.2 Novartis Pharma Description and Business Overview

6.1.3 Novartis Pharma Iptacopan Hydrochloride Capsules Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Novartis Pharma Iptacopan Hydrochloride Capsules Product Portfolio

6.1.5 Novartis Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Iptacopan Hydrochloride Capsules Industry Chain Analysis

7.2 Iptacopan Hydrochloride Capsules Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Iptacopan Hydrochloride Capsules Production Mode & Process Analysis

7.4 Iptacopan Hydrochloride Capsules Sales and Marketing

7.4.1 Iptacopan Hydrochloride Capsules Sales Channels

7.4.2 Iptacopan Hydrochloride Capsules Distributors

7.5 Iptacopan Hydrochloride Capsules Customer Analysis

8 Iptacopan Hydrochloride Capsules Market Dynamics

8.1 Iptacopan Hydrochloride Capsules Industry Trends

8.2 Iptacopan Hydrochloride Capsules Market Drivers

8.3 Iptacopan Hydrochloride Capsules Market Challenges

8.4 Iptacopan Hydrochloride Capsules Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Novartis Pharma

List of Tables

Table 1. Global Iptacopan Hydrochloride Capsules Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Iptacopan Hydrochloride Capsules Market Value by Combination Therapy (US$ Million), 2025 vs 2032

Table 3. Global Iptacopan Hydrochloride Capsules Market Value by Sales Channels (US$ Million), 2025 vs 2032

Table 4. Global Iptacopan Hydrochloride Capsules Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Iptacopan Hydrochloride Capsules Market Competitive Situation by Manufacturers in 2025

Table 6. Global Iptacopan Hydrochloride Capsules Sales (Units) of Key Manufacturers (2021–2026)

Table 7. Global Iptacopan Hydrochloride Capsules Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Iptacopan Hydrochloride Capsules Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Iptacopan Hydrochloride Capsules Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Iptacopan Hydrochloride Capsules Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Iptacopan Hydrochloride Capsules, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Iptacopan Hydrochloride Capsules, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Iptacopan Hydrochloride Capsules, Product Types and Applications

Table 14. Global Key Manufacturers of Iptacopan Hydrochloride Capsules, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Iptacopan Hydrochloride Capsules Companies by Tier (Tier 1, Tier 2, Tier 3), based on Iptacopan Hydrochloride Capsules Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Iptacopan Hydrochloride Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Iptacopan Hydrochloride Capsules Sales by Region (Units), 2021–2026

Table 20. Global Iptacopan Hydrochloride Capsules Sales Market Share by Region (2021–2026)

Table 21. Global Iptacopan Hydrochloride Capsules Sales by Region (Units), 2027–2032

Table 22. Global Iptacopan Hydrochloride Capsules Sales Market Share by Region (2027–2032)

Table 23. Global Iptacopan Hydrochloride Capsules Revenue by Region (US$ Million), 2021–2026

Table 24. Global Iptacopan Hydrochloride Capsules Revenue Market Share by Region (2021–2026)

Table 25. Global Iptacopan Hydrochloride Capsules Revenue by Region (US$ Million), 2027–2032

Table 26. Global Iptacopan Hydrochloride Capsules Revenue Market Share by Region (2027–2032)

Table 27. North America Iptacopan Hydrochloride Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Iptacopan Hydrochloride Capsules Sales by Country (Units), 2021–2026

Table 29. North America Iptacopan Hydrochloride Capsules Sales by Country (Units), 2027–2032

Table 30. North America Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2021–2026

Table 31. North America Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Iptacopan Hydrochloride Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Iptacopan Hydrochloride Capsules Sales by Country (Units), 2021–2026

Table 34. Europe Iptacopan Hydrochloride Capsules Sales by Country (Units), 2027–2032

Table 35. Europe Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Iptacopan Hydrochloride Capsules Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Iptacopan Hydrochloride Capsules Sales by Region (Units), 2021–2026

Table 39. Asia Pacific Iptacopan Hydrochloride Capsules Sales by Region (Units), 2027–2032

Table 40. Asia Pacific Iptacopan Hydrochloride Capsules Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Iptacopan Hydrochloride Capsules Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Iptacopan Hydrochloride Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Iptacopan Hydrochloride Capsules Sales by Country (Units), 2021–2026

Table 44. Latin America Iptacopan Hydrochloride Capsules Sales by Country (Units), 2027–2032

Table 45. Latin America Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Iptacopan Hydrochloride Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Iptacopan Hydrochloride Capsules Sales by Country (Units), 2021–2026

Table 49. Middle East and Africa Iptacopan Hydrochloride Capsules Sales by Country (Units), 2027–2032

Table 50. Middle East and Africa Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Iptacopan Hydrochloride Capsules Revenue by Country (US$ Million), 2027–2032

Table 52. Global Iptacopan Hydrochloride Capsules Sales (Units) by Type (2021–2026)

Table 53. Global Iptacopan Hydrochloride Capsules Sales (Units) by Type (2027–2032)

Table 54. Global Iptacopan Hydrochloride Capsules Sales Market Share by Type (2021–2026)

Table 55. Global Iptacopan Hydrochloride Capsules Sales Market Share by Type (2027–2032)

Table 56. Global Iptacopan Hydrochloride Capsules Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Iptacopan Hydrochloride Capsules Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Iptacopan Hydrochloride Capsules Revenue Market Share by Type (2021–2026)

Table 59. Global Iptacopan Hydrochloride Capsules Revenue Market Share by Type (2027–2032)

Table 60. Global Iptacopan Hydrochloride Capsules Price (US$/Unit) by Type (2021–2026)

Table 61. Global Iptacopan Hydrochloride Capsules Price (US$/Unit) by Type (2027–2032)

Table 62. Global Iptacopan Hydrochloride Capsules Sales (Units) by Application (2021–2026)

Table 63. Global Iptacopan Hydrochloride Capsules Sales (Units) by Application (2027–2032)

Table 64. Global Iptacopan Hydrochloride Capsules Sales Market Share by Application (2021–2026)

Table 65. Global Iptacopan Hydrochloride Capsules Sales Market Share by Application (2027–2032)

Table 66. Global Iptacopan Hydrochloride Capsules Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Iptacopan Hydrochloride Capsules Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Iptacopan Hydrochloride Capsules Revenue Market Share by Application (2021–2026)

Table 69. Global Iptacopan Hydrochloride Capsules Revenue Market Share by Application (2027–2032)

Table 70. Global Iptacopan Hydrochloride Capsules Price (US$/Unit) by Application (2021–2026)

Table 71. Global Iptacopan Hydrochloride Capsules Price (US$/Unit) by Application (2027–2032)

Table 72. Novartis Pharma Company Information

Table 73. Novartis Pharma Description and Business Overview

Table 74. Novartis Pharma Iptacopan Hydrochloride Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. Novartis Pharma Iptacopan Hydrochloride Capsules Product

Table 76. Novartis Pharma Recent Developments/Updates

Table 77. Key Raw Materials Lists

Table 78. Raw Materials Key Suppliers Lists

Table 79. Iptacopan Hydrochloride Capsules Distributors List

Table 80. Iptacopan Hydrochloride Capsules Customers List

Table 81. Iptacopan Hydrochloride Capsules Market Trends

Table 82. Iptacopan Hydrochloride Capsules Market Drivers

Table 83. Iptacopan Hydrochloride Capsules Market Challenges

Table 84. Iptacopan Hydrochloride Capsules Market Restraints

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Authors List of This Report

List of Figures

Figure 1. Product Picture of Iptacopan Hydrochloride Capsules

Figure 2. Global Iptacopan Hydrochloride Capsules Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Iptacopan Hydrochloride Capsules Market Share by Type: 2025 & 2032

Figure 4. 14 capsules/box Product Picture

Figure 5. 56 capsules/box Product Picture

Figure 6. Global Iptacopan Hydrochloride Capsules Market Value by Combination Therapy (US$ Million), 2021–2032

Figure 7. Global Iptacopan Hydrochloride Capsules Market Share by Combination Therapy: 2025 vs 2032

Figure 8. Combined With Renin-Angiotensin-Aldosterone System Inhibitors Product Picture

Figure 9. Combined With Corticosteroids Product Picture

Figure 10. Global Iptacopan Hydrochloride Capsules Market Value by Sales Channels (US$ Million), 2021–2032

Figure 11. Global Iptacopan Hydrochloride Capsules Market Share by Sales Channels: 2025 vs 2032

Figure 12. Hospital Product Picture

Figure 13. Retail Product Picture

Figure 14. Online Product Picture

Figure 15. Global Iptacopan Hydrochloride Capsules Market Value by Application (US$ Million), 2021–2032

Figure 16. Global Iptacopan Hydrochloride Capsules Market Share by Application: 2025 & 2032

Figure 17. Treatment Of IgA Nephropathy

Figure 18. Treatment Of C3 Glomerulopathy

Figure 19. Treatment Of Complement-Mediated Renal Diseases

Figure 20. Others

Figure 21. Global Iptacopan Hydrochloride Capsules Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global Iptacopan Hydrochloride Capsules Market Size (US$ Million), 2021–2032

Figure 23. Global Iptacopan Hydrochloride Capsules Sales (Units), 2021–2032

Figure 24. Global Iptacopan Hydrochloride Capsules Average Price (US$/Unit), 2021–2032

Figure 25. Iptacopan Hydrochloride Capsules Report Years Considered

Figure 26. Iptacopan Hydrochloride Capsules Sales Share by Manufacturers in 2025

Figure 27. Global Iptacopan Hydrochloride Capsules Revenue Share by Manufacturers in 2025

Figure 28. Top 5 and Top 10 Global Iptacopan Hydrochloride Capsules Players: Market Share by Revenue in Iptacopan Hydrochloride Capsules in 2025

Figure 29. Iptacopan Hydrochloride Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 30. Global Iptacopan Hydrochloride Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 31. North America Iptacopan Hydrochloride Capsules Sales Market Share by Country (2021–2032)

Figure 32. North America Iptacopan Hydrochloride Capsules Revenue Market Share by Country (2021–2032)

Figure 33. United States Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Canada Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Europe Iptacopan Hydrochloride Capsules Sales Market Share by Country (2021–2032)

Figure 36. Europe Iptacopan Hydrochloride Capsules Revenue Market Share by Country (2021–2032)

Figure 37. Germany Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. France Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. U.K. Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Italy Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Russia Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Asia Pacific Iptacopan Hydrochloride Capsules Sales Market Share by Region (2021–2032)

Figure 43. Asia Pacific Iptacopan Hydrochloride Capsules Revenue Market Share by Region (2021–2032)

Figure 44. China Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Japan Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. South Korea Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. India Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Australia Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. China Taiwan Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Southeast Asia Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Latin America Iptacopan Hydrochloride Capsules Sales Market Share by Country (2021–2032)

Figure 52. Latin America Iptacopan Hydrochloride Capsules Revenue Market Share by Country (2021–2032)

Figure 53. Mexico Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Brazil Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Argentina Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Colombia Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Middle East and Africa Iptacopan Hydrochloride Capsules Sales Market Share by Country (2021–2032)

Figure 58. Middle East and Africa Iptacopan Hydrochloride Capsules Revenue Market Share by Country (2021–2032)

Figure 59. Turkey Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Saudi Arabia Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. UAE Iptacopan Hydrochloride Capsules Revenue Growth Rate (US$ Million), 2021–2032

Figure 62. Global Sales Market Share of Iptacopan Hydrochloride Capsules by Type (2021–2032)

Figure 63. Global Revenue Market Share of Iptacopan Hydrochloride Capsules by Type (2021–2032)

Figure 64. Global Iptacopan Hydrochloride Capsules Price (US$/Unit) by Type (2021–2032)

Figure 65. Global Sales Market Share of Iptacopan Hydrochloride Capsules by Application (2021–2032)

Figure 66. Global Revenue Market Share of Iptacopan Hydrochloride Capsules by Application (2021–2032)

Figure 67. Global Iptacopan Hydrochloride Capsules Price (US$/Unit) by Application (2021–2032)

Figure 68. Iptacopan Hydrochloride Capsules Value Chain

Figure 69. Channels of Distribution (Direct Vs Distribution)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions